Evaluation of the decellularized pulmonary valve homograft (SynerGraft).

Background And Aim Of The Study: Rejection is thought to contribute to the degeneration of valved homografts. A novel cryopreserved decellularized homograft valve (SynerGraft; CryoLife, Inc.) offers the unique opportunity to gain new insight into the immunology of homograft implantation and its significance for valve function.